For the full 2012 fiscal year, the company’s revenue grew 5 percent to $3.6 billion. Success in the fourth quarter was driven by the company’s medical system’s segment, while the procedural solutions segment met expectations.
The company’s operating expenses were down 7 percent during the fourth quarter, totaling $313 million. The company increased research and development investments by 21 percent to $46 million.
During the fourth quarter, the company’s medical systems segment reached $646 million, driven by record installations in Infusion Systems and double-digit increases in respiratory technologies and dispensing technologies.
More Articles on CareFusion:
CareFusion Releases 11-Guage Vertebral Balloon for Spinal Fracture Treatment
CareFusion Launches AVAmax Vertebral Balloon for Kyphoplasty
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.